(2S,3R,5R)-2-(2,4-Difluoro-phenylsulfanylmethyl)-5-{6-[(R)-(tetrahydro-furan-3-yl)amino]-purin-9-yl}-tetrahydro-furan-3,4-diol

ID: ALA2092779

PubChem CID: 59991900

Max Phase: Preclinical

Molecular Formula: C20H21F2N5O4S

Molecular Weight: 465.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O[C@@H]1[C@H](O)[C@@H](CSc2ccc(F)cc2F)O[C@H]1n1cnc2c(NC3CCOC3)ncnc21

Standard InChI:  InChI=1S/C20H21F2N5O4S/c21-10-1-2-14(12(22)5-10)32-7-13-16(28)17(29)20(31-13)27-9-25-15-18(23-8-24-19(15)27)26-11-3-4-30-6-11/h1-2,5,8-9,11,13,16-17,20,28-29H,3-4,6-7H2,(H,23,24,26)/t11?,13-,16-,17-,20-/m1/s1

Standard InChI Key:  GJLUJCRJDFVKER-OFGIKRIPSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    5.5157   -1.9883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4699   -2.8077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3018   -1.7388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3060   -0.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5281   -0.6531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1829   -3.5814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0332   -1.3145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8210   -2.2961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0256   -0.5116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3593   -3.5482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430   -2.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0131   -2.1588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7369   -0.9276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0298    0.3120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3253   -0.5615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7286   -1.7512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2320   -1.6514    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.5516   -0.2745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4583   -1.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3693   -2.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6322   -4.2595    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0514    0.9858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8261   -1.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9152   -0.8028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8435   -4.1846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9575   -0.0292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.7494    0.7196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0607   -1.6140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1415   -0.5158    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8367    1.5432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6396    1.7054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4981    0.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  1  1  0
  4  3  2  0
  5  7  2  0
  6  2  1  0
  7  1  1  0
  8  2  1  0
  9  4  1  0
 10  6  1  0
 11  8  1  0
 12  3  1  0
 13 16  1  0
 14  9  1  0
 15 19  2  0
 16 12  2  0
 17 20  1  0
 18 15  1  0
 19 17  1  0
 11 20  1  1
  6 21  1  6
 22 32  1  0
 23 19  1  0
 24 28  1  0
 10 25  1  6
 26 15  1  0
 27 14  1  0
 28 23  2  0
 29 24  1  0
 30 27  1  0
 31 30  1  0
 32 27  1  0
  5  4  1  0
 10 11  1  0
  9 13  2  0
 31 22  1  0
 24 18  2  0
M  END

Associated Targets(non-human)

ADORA1 Adenosine A1 receptor (540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.48Molecular Weight (Monoisotopic): 465.1282AlogP: 1.72#Rotatable Bonds: 6
Polar Surface Area: 114.55Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.47CX Basic pKa: 3.71CX LogP: 1.26CX LogD: 1.26
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.47Np Likeness Score: -0.25

References

1. Morrison CF, Elzein E, Jiang B, Ibrahim PN, Marquart T, Palle V, Shenk KD, Varkhedkar V, Maa T, Wu L, Wu Y, Zeng D, Fong I, Lustig D, Leung K, Zablocki JA..  (2004)  Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents.,  14  (14): [PMID:15203164] [10.1016/j.bmcl.2004.04.096]
2. Morrison CF, Elzein E, Jiang B, Ibrahim PN, Marquart T, Palle V, Shenk KD, Varkhedkar V, Maa T, Wu L, Wu Y, Zeng D, Fong I, Lustig D, Leung K, Zablocki JA..  (2004)  Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents.,  14  (14): [PMID:15203164] [10.1016/j.bmcl.2004.04.096]

Source